Clinical trials
Phase 4 Coronary Artery Disease trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
| Abbott Medical Devices | 1 |
| Gilead Sciences | 1 |
| Institute for Atherosclerosis Research, Russia | 1 |
| Saint Petersburg State University, Russia | 1 |
| Tomsk Cardiology Research Institute | 1 |
| Ural State Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 8 |
| Diabetes Mellitus, Type 2 | 2 |
| Myocardial Ischemia | 2 |
| Angina Pectoris | 1 |
| Atrial Fibrillation | 1 |
| Cerebrovascular Disorders | 1 |
| Coronary Restenosis | 1 |
| Coronary Stenosis | 1 |
| Dyslipidemias | 1 |
| Hypercholesterolemia | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.